581 related articles for article (PubMed ID: 11411106)
21. [Effect of prophylactic intravesical instillation of BCG for superficial bladder cancer].
Segawa N; Inamoto T; Nomi H; Ibuki N; Azuma H; Katsuoka Y
Hinyokika Kiyo; 2009 Apr; 55(4):175-80. PubMed ID: 19462820
[TBL] [Abstract][Full Text] [Related]
22. Granulomatous balanoposthitis after intravesical Bacillus-Calmette-Guerin instillation therapy.
Yusuke H; Yoshinori H; Kenichi M; Akio H
Int J Urol; 2006 Oct; 13(10):1361-3. PubMed ID: 17010022
[TBL] [Abstract][Full Text] [Related]
23. [Long-term results and complications of intravesical instillation of bacillus Calmette-Guerin for prophylaxis of bladder cancer recurrence].
Irie A; Lee KE; Kadowaki K; Sawamura M
Hinyokika Kiyo; 1994 Oct; 40(10):873-7. PubMed ID: 7992700
[TBL] [Abstract][Full Text] [Related]
24. The ablative effect of quarter dose bacillus Calmette-Guerin on a papillary marker lesion of the bladder.
Mack D; Höltl W; Bassi P; Brausi M; Ferrari P; de Balincourt C; Sylvester R;
J Urol; 2001 Feb; 165(2):401-3. PubMed ID: 11176382
[TBL] [Abstract][Full Text] [Related]
25. [Transitional cell carcinoma in prostate after intravesical instillation of Bacillus Calmette-Guerin].
Ito Y; Nishiyama H; Higashi S; Kinoshita H; Ito N; Yamamoto S; Kamoto T; Ogawa O
Hinyokika Kiyo; 2004 May; 50(5):335-8. PubMed ID: 15237488
[TBL] [Abstract][Full Text] [Related]
26. [Intravesical BCG therapy for superficial bladder cancer].
Segawa N; Iwamoto Y; Azuma H; Yamamoto K; Ueda H; Katsuoka Y
Hinyokika Kiyo; 1998 Sep; 44(9):627-31. PubMed ID: 9805666
[TBL] [Abstract][Full Text] [Related]
27. Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome.
Hausladen DA; Wheeler MA; Altieri DC; Colberg JW; Weiss RM
J Urol; 2003 Jul; 170(1):230-4. PubMed ID: 12796695
[TBL] [Abstract][Full Text] [Related]
28. Intravesical bacillus Calmette-Guérin therapy for T1 superficial bladder cancer.
Demkow T; Alter A; Wiechno P
Urol Int; 2008; 80(1):74-9. PubMed ID: 18204238
[TBL] [Abstract][Full Text] [Related]
29. [Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer].
Yamada Y; Washida H; Tozawa K; Honma H; Kang K
Hinyokika Kiyo; 1994 Jul; 40(7):575-9. PubMed ID: 8085517
[TBL] [Abstract][Full Text] [Related]
30. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
[TBL] [Abstract][Full Text] [Related]
31. [Intravesical bacillus Calmette-Guerin in the treatment of recurrent superficial bladder tumors].
Nakano M; Iwamuro S; Fujii H; Kondoh I
Hinyokika Kiyo; 1988 Jun; 34(6):983-6. PubMed ID: 3223463
[TBL] [Abstract][Full Text] [Related]
32. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.
Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D
Prog Clin Biol Res; 1989; 310():325-34. PubMed ID: 2672020
[TBL] [Abstract][Full Text] [Related]
33. [A case of transitional cell carcinoma with squamous differentiation which developed squamous cell carcinoma in situ in the clinical course].
Sugiura S; Makiyama K; Yokomizo Y; Umemoto S; Miyoshi Y; Nakaigawa N; Ogawa T; Uemurai H; Yao M; Kubota Y; Yamanaka S
Hinyokika Kiyo; 2006 Sep; 52(9):715-8. PubMed ID: 17040058
[TBL] [Abstract][Full Text] [Related]
34. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
Fujimoto K; Chihara Y; Kondo H; Hirao Y
Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
[TBL] [Abstract][Full Text] [Related]
35. [Assessment of 8-hydroxy-2'-deoxyguanosine concentrations in bladder cancer patients treated with intravesical BCG instillation].
Kaczmarek P; Błaszczyk J; Fijałkowski P; Sierakowska-Fijałek A; Niemirowicz J; Kasprzak A; Baj Z
Pol Merkur Lekarski; 2005 Oct; 19(112):526-8. PubMed ID: 16379317
[TBL] [Abstract][Full Text] [Related]
36. [Is second course intravesical Bacillus Calmette-Guerin therapy for recurrent carcinoma in situ of the bladder useful?].
Yamada Y; Hara I; Kumano M; Furukawa J; Yamanaka K; Kamidono S
Hinyokika Kiyo; 2005 Aug; 51(8):539-43. PubMed ID: 16164270
[TBL] [Abstract][Full Text] [Related]
37. Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin.
Nativ O; Witjes JA; Hendricksen K; Cohen M; Kedar D; Sidi A; Colombo R; Leibovitch I
J Urol; 2009 Oct; 182(4):1313-7. PubMed ID: 19683278
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
Yossepowitch O; Eggener SE; Bochner BH; Donat SM; Herr HW; Dalbagni G
J Urol; 2006 Aug; 176(2):482-5. PubMed ID: 16813873
[TBL] [Abstract][Full Text] [Related]
39. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
[TBL] [Abstract][Full Text] [Related]
40. [Reiter syndrome after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy: a case report].
Shiba M; Fujii T; Takatera H
Hinyokika Kiyo; 2003 Oct; 49(10):599-601. PubMed ID: 14655604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
